Detailed Classification Data Enables Targetted Drug Development
Disease data is at the heart of the development of targeted drug treatments as well as enhanced accuracy in reimbursement and pricing strategies. As research into new drugs moves forward, the data challenges for life science companies include ensuring that international classification data is accurate and up to date.
This opens up opportunities to stratify patient populations for better identification and understanding of target patient populations, so that the right patient gets access to the right treatment.
Navigant experts look at how life sciences companies are harnessing International Classification of Diseases (ICD) data as part of their drug research and development strategy in the article "Coding For Success: Are You Making The Most Of ICD Classification?"